NEW YORK, NY / ACCESSWIRE / December 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

ADMS Shareholders Click Here: https://www.zlk.com/pslra-1/adamas-pharmaceuticals-inc-loss-form?prid=4994&wire=1
PLT Shareholders Click Here: https://www.zlk.com/pslra-1/plantronics-inc-loss-form?prid=4994&wire=1
HEXO Shareholders Click Here: https://www.zlk.com/pslra-1/hexo-corp-loss-form?prid=4994&wire=1

* ADDITIONAL INFORMATION BELOW *

Adamas Pharmaceuticals, Inc. (NASDAQGM:ADMS)

ADMS Lawsuit on behalf of: investors who purchased August 8, 2017 – September 30, 2019
Lead Plaintiff Deadline : February 10, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/adamas-pharmaceuticals-inc-loss-form?prid=4994&wire=1

According to the filed complaint, during the class period, Adamas Pharmaceuticals, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) health insurers were excluding Adamas's primary product, GOCOVRI, from their prescription formularies or requiring patients to use "step therapy" – i.e., making patients try immediate-release amantadine prior to covering GOCOVRI; (2) the rapid increase in physicians prescribing GOCOVRI during the Class Period was not due to its efficacy; and (3) as a result of the foregoing, the Company's financial statements about Adamas's business, operations, and prospects were materially false and misleading at all relevant times.

Plantronics, Inc. (NYSE:PLT)

PLT Lawsuit on behalf of: investors who purchased July 2, 2018 – November 5, 2019
Lead Plaintiff Deadline : January 13, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/plantronics-inc-loss-form?prid=4994&wire=1

According to the filed complaint, during the class period, Plantronics, Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) the Company had engaged in channel stuffing to artificially boost sales; (2) the Company's internal control over inventory levels was not effective; (3) the Company had not adequately monitored inventory levels ahead of multiple product launches, where the new models would displace demand for aging products; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

HEXO Corp. (NYSE:HEXO)

HEXO Lawsuit on behalf of: investors who purchased January 25, 2019 – November 15, 2019
Lead Plaintiff Deadline : January 27, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/hexo-corp-loss-form?prid=4994&wire=1

According to the filed complaint, during the class period, HEXO Corp. made materially false and/or misleading statements and/or failed to disclose that: (1) HEXO's reported inventory was misstated as the Company was failing to write down or write off obsolete product that no longer had value; (2) HEXO was engaging in channel-stuffing in order to inflate its revenue figures and meet or exceed revenue guidance provided to investors; (3) HEXO was cultivating cannabis at its facility in Niagara, Ontario that was not appropriately licensed by Health Canada; and (4) as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects, were materially misleading and/or lacked a reasonable basis.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570952

VANCOUVER, BC / ACCESSWIRE / December 20, 2019 / Black Tusk Resources Inc. (the "Company") (CSE:TUSK) (Frankfurt: 0NB) (OTC PINK:BTKRF) is pleased to announce that it has closed a flow through private placement issuing a total of 3,300,000 Units (as defined below) at a price of $0.055 per Unit for total proceeds of $181,500.

Each Unit consists of one flow-through common share (a "Share") and one half of one share purchase warrant (each whole warrant a "Warrant"). Each Warrant will entitle the holder to purchase an additional share at a price of $0.10 per share for a two-year term (the "Warrant Term").

The Company paid finders fees to Leede Jones Gable Inc. and EMD Financial Inc. consisting of $13,200 cash, 144,000 common shares and 48,000 Warrants.

On behalf of the Board of Directors

Richard Penn,
CEO

CONTACT:

Roman Rubin
(CSE:TUSK)
Chief Financial Officer
500-666 Burrard st.
Vancouver, BC, V6C 3P6
Office: 604-373-TUSK (8875)
Toll free: 1-833-273-TUSK (8875)

SOURCE: Black Tusk Resources Inc.

ReleaseID: 570949

NEW YORK, NY / ACCESSWIRE / December 20, 2019 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court. Further details about the cases can be found at the links provided. There is no cost or obligation to you.

SEE Shareholders Click Here: https://www.zlk.com/pslra-1/sealed-air-corporation-loss-form?prid=4993&wire=1
GDOT Shareholders Click Here: https://www.zlk.com/pslra-1/green-dot-corporation-loss-form?prid=4993&wire=1
ACB Shareholders Click Here: https://www.zlk.com/pslra-1/aurora-cannabis-inc-loss-form?prid=4993&wire=1

* ADDITIONAL INFORMATION BELOW *

Sealed Air Corporation (NYSE:SEE)

SEE Lawsuit on behalf of: investors who purchased November 5, 2014 – August 6, 2018
Lead Plaintiff Deadline : December 31, 2019
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/sealed-air-corporation-loss-form?prid=4993&wire=1

According to the filed complaint, during the class period, Sealed Air Corporation made materially false and/or misleading statements and/or failed to disclose that: (a) Sealed Air had hired its auditor, E&Y, pursuant to a conflicted and improper process and in order to help facilitate defendants' efforts to engage in accounting fraud; (b) Sealed Air's deduction of $1.49 billion in connection with the Settlement was indefensible and done for the improper purpose of artificially inflating the Company's financial results; (c) Sealed Air had artificially inflated its earnings, cash flows, and operating income during the Class Period; (d) as a result of the above, Sealed Air's Class Period financial statements were materially false and misleading and not prepared in conformance with GAAP; and (e) as a result of the above, Sealed Air's statements regarding its financial results, business, and prospects were materially misleading.

Green Dot Corporation (NYSE:GDOT)

GDOT Lawsuit on behalf of: investors who purchased May 9, 2018 – November 7, 2019
Lead Plaintiff Deadline : February 17, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/green-dot-corporation-loss-form?prid=4993&wire=1

According to the filed complaint, during the class period, Green Dot Corporation made materially false and/or misleading statements and/or failed to disclose that: (1) Green Dot's strategy to attract "high-value" long-term customers was at the expense of "one and done" customers; (2) Green Dot's "one and done" customers represented a significant source of revenues in its legacy segment; (3) consequently, Green Dot's strategy was self-sabotaging; and (4) as a result of the foregoing, Defendants' statements about its business and operations were materially false and misleading at all relevant times.

Aurora Cannabis Inc. (NYSE:ACB)

ACB Lawsuit on behalf of: investors who purchased September 11, 2019 – November 14, 2019
Lead Plaintiff Deadline : January 21, 2020
TO LEARN MORE, VISIT: https://www.zlk.com/pslra-1/aurora-cannabis-inc-loss-form?prid=4993&wire=1

According to the filed complaint, during the class period, Aurora Cannabis Inc. made materially false and/or misleading statements and/or failed to disclose that: (1) as opposed to the Company's representations, Aurora's revenue would decline in its first quarter of fiscal 2020 ended September 30, 2019; (2) the Company would halt construction on its Aurora Nordic 2 and Aurora Sun facilities; and (3) as a result, Defendants' statements about its business, operations, and prospects, were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You have until the lead plaintiff deadlines to request that the court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.

Levi & Korsinsky is a national firm with offices in New York, California, Connecticut, and Washington D.C. The firm's attorneys have extensive expertise and experience representing investors in securities litigation and have recovered hundreds of millions of dollars for aggrieved shareholders. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph E. Levi, Esq.
55 Broadway, 10th Floor
New York, NY 10006
jlevi@levikorsinsky.com
Tel: (212) 363-7500
Fax: (212) 363-7171
www.zlk.com

SOURCE: Levi & Korsinsky, LLP

ReleaseID: 570950

LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against PG&E Corporation ("PG&E" or ''the Company'') (NYSE:PCG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between December 11, 2018 and October 11, 2019, inclusive (the ''Class Period''), are encouraged to contact the

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. PG&E's supposedly enhanced protocols for wildfire prevention and safety were not sufficient to solve the very problems they were designed to mitigate. The Company was completely unprepared for rolling power cuts to minimize the risk of wildfires. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about PG&E, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570946

LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Baozun Inc. ("Baozun" or "the Company") (NASDAQ:BZUN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between March 6, 2019 and November 20, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 10, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. One of Baozun's largest brand partners, Huawei, paid it add-on fees other partners did typically not pay, increasing the Company's revenues. This arrangement boosted the Company's revenues in the first half of 2019, only to abruptly drop them as Huawei restructured its online merchandising in the second half of the year. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Baozun, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570943

LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Exelon Corporation ("Exelon" or "the Company") (NASDAQ:EXC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 9, 2019 and November 1, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before February 14, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Exelon and its employees engaged in improper lobbying of government officials. These actions increased the likelihood of a criminal investigation of the Company. Exelon subsidiary Commonwealth Edison gained revenues as a result of the improper conduct which would be unsustainable in the future. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Exelon, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570942

LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces it has filed a class action lawsuit against Baxter International Inc. ("Baxter" or "the Company") (NYSE:BAX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between February 21, 2019 and October 23, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before January 24, 2020.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Baxter engaged in intra-Company transactions designed to generate gains from foreign exchanges that did not follow GAAP principles and were undertaken when the foreign exchange rates were already known. The Company failed to maintain effective controls on financial reporting. Based on the Company's internal investigation of these matters, it was not capable of filing a Form 10-Q quarterly report for the period ending September 30, 2019. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Baxter, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm
Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570941

NEW YORK, NY / ACCESSWIRE / December 20, 2019 / The securities litigation law firm of The Gross Law Firm issues the following notice on behalf of shareholders in the following publicly traded companies. Shareholders who purchased shares in the following companies during the dates listed are encouraged to contact the firm regarding possible Lead Plaintiff appointment. Appointment as Lead Plaintiff is not required to partake in any recovery.

The RealReal, Inc. (NASDAQ:REAL)

Investors Affected: all persons and entities who purchased RealReal common stock pursuant and/or traceable to the Company's registration statement issued in connection with the Company's June 27, 2019 initial public offering.

A class action has commenced on behalf of certain shareholders in The RealReal, Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) the Company's employees received little training on how to spot fake items; (2) the Company's strict quotas on its employees exacerbated product authentication issues; (3) consequently, the potential for counterfeit or mislabeled items to make it through Company's authentication process was higher than disclosed; and (4) as a result, Defendants' statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/the-realreal-inc-loss-submission-form/?id=4992&from=1

Mylan N.V. (NASDAQ:MYL)

Investors Affected: May 9, 2018 – May 6, 2019

A class action has commenced on behalf of certain shareholders in Mylan NV. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (1) Mylan's Morgantown facility was in significant violation of the FDA's Current Good Manufacturing Practice regulations; (2) Mylan would need to engage in a massive restructuring and remediation program; (3) Mylan's North American Segment would be substantially impacted by said program, which would in turn materially impact Mylan's financial health; (3) Mylan lacked effective internal control over financial reporting; and (4) as a result of the foregoing, the Company's financial statements were materially false and misleading at all relevant times.

Shareholders may find more information at https://securitiesclasslaw.com/securities/mylan-n-v-loss-submission-form/?id=4992&from=1

Grubhub Inc. (NYSE:GRUB)

Investors Affected: July 30, 2019 – October 28, 2019

A class action has commenced on behalf of certain shareholders in Grubhub Inc. The filed complaint alleges that defendants made materially false and/or misleading statements and/or failed to disclose that: (i) customer orders were actually declining, despite the massive investments that the Company had made to spur demand for and use of its platform; (ii) Grubhub's new customer additions were generating significantly lower revenues as compared to historic cohorts because these customers were more prone to using competitor platforms; (iii) Grubhub's vaunted business model under which it secured exclusive partnerships had failed, and Grubhub needed to engage in the same aggressive nonpartnered sales tactics embraced by its competitors to generate significant revenue growth; (iv) Grubhub was required to spend substantial additional capital in order to grow revenues and retain market share in the face of heightened competitive dynamics and market saturation, eviscerating the Company's profitability; and (v) Grubhub was tracking tens of millions of dollars below its revenue and earnings guidance and such guidance lacked any reasonable basis.

Shareholders may find more information at https://securitiesclasslaw.com/securities/grubhub-inc-loss-submission-form/?id=4992&from=1

The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The firm seeks recovery on behalf of investors who incurred losses when false and/or misleading statements or the omission of material information by a Company lead to artificial inflation of the Company's stock. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:

The Gross Law Firm
15 West 38th Street, 12th floor
New York, NY, 10018
Email: dg@securitiesclasslaw.com
Phone: (212) 537-9430
Fax: (833) 862-7770

SOURCE: The Gross Law Firm

ReleaseID: 570940

VANCOUVER, BC / ACCESSWIRE / December 20, 2019 / Organto Foods Inc. (TSXV:OGO)(OTC:OGOFF) ("Organto" or the "Company"). Organto today announced that it has closed the sale of the Company's former Colombian cannabis subsidiary, Medicannabis S.A.S. ("Medicannabis") to Xebra Brands Ltd. ("Xebra"). Organto had announced previously that it had received both shareholder approval and acceptance of the TSX Venture Exchange, subject to certain closing deliverables which have now been completed.

Xebra is a private cannabis company, focused on the design and delivery of unique wellness and leisure products. It has acquired cultivation and processing licences in Colombia, and is developing brands, and cannabis-infused beverages, for sale globally where cannabis is legal. Trademarks are being filed worldwide for Xebra's inaugural cannabis infused beverage brands, including: MADCAP soft drinks, HIGHJACK energy drinks, HolaHi iced teas, VICIOUS CITRUS lemonade, and CONQUER sports drinks. Xebra's Mexican subsidiaries Elements Bioscience and Sativa Group, specialize in CBD wellness products, with 13 applications awaiting approval. Xebra is aiming for a public listing in Q2 2020. As per the terms of the agreement with Xebra, Organto received 7,124,630 common shares of Xebra, representing approximately 7.44% of the current proforma outstanding shares of Xebra.

"We are pleased to have closed this transaction and are excited to be a shareholder of Xebra, providing Organto with an important asset for the future. We believe Xebra's continued execution of their business plan should create tremendous shareholder value that can be monetized in the future for the benefit Organto's shareholders," commented Steve Bromley, Chair and Interim CEO of Organto Foods Inc. "With this transaction we will continue to have an investment in this exciting and fast-growing sector while focusing operationally on our fast-growing organic vegetables and fruit platform."

Steve Bromley
Chair and Interim Chief Executive Officer

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.

For more information contact:

Investor Relations
604-634-0970
1-888-818-1364
info@organto.com

ABOUT ORGANTO

Organto's business model is rooted in its commitment to sustainable business practices focused on environmental responsibility and a commitment to the communities where it operates, its people and its shareholders. The Organto Foods Group is an integrated provider of year-round value-added branded organic vegetables and seasonal organic and non-GMO fruit and vegetable products using an asset-light business model to serve a growing socially responsible and health conscious consumer around the globe.

FORWARD LOOKING STATEMENTS

This news release may include certain forward-looking information and statements, as defined by law including without limitation Canadian securities laws and the "safe harbor" provisions of the US Private Securities Litigation Reform Act of 1995 ("forward-looking statements"). In particular, and without limitation, this news release contains forward-looking statements respecting Organto's current business model and related expertise; Organto's belief that Xebra's execution of their business plan should create tremendous value for shareholder's of Organto that may be monetized; Organto's belief that the opportunity in organic vegetables and fruits is fast growing; management's beliefs, assumptions and expectations; and general business and economic conditions. Forward-looking statements are based on a number of assumptions that may prove to be incorrect, including without limitation assumptions about the following: the ability and time frame within which Organto's business model will be implemented; cost increases; dependence on suppliers, partners and contractual counter-parties; changes in the business or prospects of Organto; unforeseen circumstances; risks associated with the organic produce business generally, including inclement weather, unfavorable growing conditions, low crop yields, variations in crop quality, spoilage, import and export laws and similar risks; transportation costs and risks; general business and economic conditions; ongoing relations with distributors, customers, employees, suppliers, consultants, contractors and partners and joint venturers; and risks associated with cannabis operations and receipt of required licenses in Colombia. The foregoing list is not exhaustive and Organto undertakes no obligation to update any of the foregoing except as required by law.

SOURCE: Organto Foods Inc.

ReleaseID: 570938

LOS ANGELES, CA / ACCESSWIRE / December 20, 2019 / The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Infosys Limited ("Infosys" or "the Company") (NYSE:INFY) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.

Investors who purchased the Company's securities between July 7, 2018 and October 20, 2019, inclusive (the ''Class Period''), are encouraged to contact the firm before December 23, 2019.

If you are a shareholder who suffered a loss, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.

The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.

According to the Complaint, the Company made false and misleading statements to the market. Infosys used improper recognition of revenue to boost short-term profits. CEO Salil Parekh skipped standard reviews of large deals to avoid accounting scrutiny. In fact, the Company's finance team was pressured to hide details of these deals and other accounting matters from auditors and the Company's Board of Directors. Based on these facts, the Company's public statements were false and materially misleading throughout the class period. When the market learned the truth about Infosys, investors suffered damages.

Join the case to recover your losses.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

Brian Schall, Esq.,
www.schallfirm.com
Office: 310-301-3335
Cell: 424-303-1964
info@schallfirm.com

SOURCE: The Schall Law Firm

ReleaseID: 570939